Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
- Chamber
- House
- Introduced
- May 4, 2026
- Last action
- May 4, 2026 — REFERRED TO INSURANCE
- Session
- 2025-2026
- Momentum
- 26 · Low